Inhibition of ferrous‐induced lipid peroxidation by pyrimido‐pyrimidine derivatives in human liver membranes
- 1 March 1992
- Vol. 27 (3) , 192-194
- https://doi.org/10.1007/bf02536177
Abstract
The effects of pyrimido-pyrimidine derivatives (dipyridamole, RA-642, and RA-233) on lipid peroxidation, using d-α-tocopherol as standard, were studied in enriched membrane fractions from human and rat hepatocytes. Equimolar concentrations of ferrous sulfate and ascorbic acid were used to induce lipid peroxidation. The amount of peroxidized lipids observed in membrane fractions from human liver was smaller than in those from rat liver. In both species, however, pyrimido-pyrimidine derivatives, except for RA-233 in rat liver, inhibited lipid peroxidation dose-dependently in the following sequence: RA-642 > dipyridamole > d-α-tocopherol RA-233.Keywords
This publication has 17 references indexed in Scilit:
- Dipyridamole and RA‐642 Inhibit the Production of Superoxide Anion and Free Radical Damage to Rat LensBasic & Clinical Pharmacology & Toxicology, 1991
- Antiplatelet effect of the pyrimido-pyrimidinic derivative RA-642Thrombosis Research, 1991
- Effects of Dipyridamole on the Short-Term Evolution of GlomerulonephritisNephron, 1991
- How to Characterize a Biological AntioxidantFree Radical Research Communications, 1990
- Dipyridamole inhibits lipid peroxidation and scavenges oxygen radicalsLipids, 1989
- The role of lipid peroxidation in liver damageChemistry and Physics of Lipids, 1987
- Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lensExperimental Eye Research, 1983
- Potentiation of lipid peroxides by ischemia in rat brainNeurochemical Research, 1982
- Drug-induced lipid peroxidation in mice—I Modulation by monooxegenase activity, glutathione and selenium statusBiochemical Pharmacology, 1981
- EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOURThe Lancet, 1965